Compare Dr. Reddys with NEULAND LABS - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs NEULAND LABS - Comparison Results

DR. REDDYS LAB     Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the pharmaceutical value chain - basic research, finished dosages, generics, bulk actives, and biotechnology. The company's business is mainly organized into Global g... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB NEULAND LABS DR. REDDYS LAB/
NEULAND LABS
 
P/E (TTM) x 39.3 59.9 65.6% View Chart
P/BV x 5.4 4.5 118.7% View Chart
Dividend Yield % 0.5 0.1 619.2%  

Financials

 DR. REDDYS LAB   NEULAND LABS
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-20
NEULAND LABS
Mar-20
DR. REDDYS LAB/
NEULAND LABS
5-Yr Chart
Click to enlarge
High Rs3,363754 446.3%   
Low Rs2,352247 951.1%   
Sales per share (Unadj.) Rs1,054.2594.5 177.3%  
Earnings per share (Unadj.) Rs121.912.6 965.1%  
Cash flow per share (Unadj.) Rs190.237.0 513.9%  
Dividends per share (Unadj.) Rs25.002.00 1,250.0%  
Dividend yield (eoy) %0.90.4 218.9%  
Book value per share (Unadj.) Rs938.7553.4 169.6%  
Shares outstanding (eoy) m166.1712.83 1,295.2%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.70.8 322.0%   
Avg P/E ratio x23.439.6 59.2%  
P/CF ratio (eoy) x15.013.5 111.1%  
Price / Book Value ratio x3.00.9 336.6%  
Dividend payout %20.515.8 129.5%   
Avg Mkt Cap Rs m474,8316,421 7,395.2%   
No. of employees `00021.71.3 1,688.8%   
Total wages/salary Rs m33,8021,236 2,735.8%   
Avg. sales/employee Rs Th8,091.05,949.4 136.0%   
Avg. wages/employee Rs Th1,561.3963.8 162.0%   
Avg. net profit/employee Rs Th935.8126.4 740.2%   
INCOME DATA
Net Sales Rs m175,1707,627 2,296.7%  
Other income Rs m6,20639 15,974.3%   
Total revenues Rs m181,3767,666 2,366.0%   
Gross profit Rs m24,4211,019 2,396.8%  
Depreciation Rs m11,348313 3,627.9%   
Interest Rs m983216 455.7%   
Profit before tax Rs m18,296529 3,457.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m5610-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,403367 -382.2%   
Profit after tax Rs m20,260162 12,500.0%  
Gross profit margin %13.913.4 104.4%  
Effective tax rate %-7.769.4 -11.1%   
Net profit margin %11.62.1 544.3%  
BALANCE SHEET DATA
Current assets Rs m125,9915,152 2,445.5%   
Current liabilities Rs m72,1413,576 2,017.2%   
Net working cap to sales %30.720.7 148.8%  
Current ratio x1.71.4 121.2%  
Inventory Days Days73105 69.5%  
Debtors Days Days10591 115.3%  
Net fixed assets Rs m83,8543,969 2,113.0%   
Share capital Rs m831129 644.2%   
"Free" reserves Rs m155,1576,971 2,225.9%   
Net worth Rs m155,9887,100 2,197.1%   
Long term debt Rs m1,304774 168.5%   
Total assets Rs m232,25312,310 1,886.7%  
Interest coverage x19.63.5 568.0%   
Debt to equity ratio x00.1 7.7%  
Sales to assets ratio x0.80.6 121.7%   
Return on assets %9.13.1 298.0%  
Return on equity %13.02.3 568.9%  
Return on capital %12.69.5 133.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m84,1935,187 1,623.2%   
Fx outflow Rs m39,6161,593 2,487.2%   
Net fx Rs m44,5773,594 1,240.4%   
CASH FLOW
From Operations Rs m29,841573 5,204.2%  
From Investments Rs m-4,923-487 1,011.3%  
From Financial Activity Rs m-25,159-55 45,910.6%  
Net Cashflow Rs m-26633 -816.0%  

Share Holding

Indian Promoters % 25.5 36.3 70.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 5.4 63.7 8.5%  
FIIs % 35.3 0.0 -  
ADR/GDR % 18.5 0.0 -  
Free float % 15.3 63.7 24.0%  
Shareholders   75,885 12,705 597.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   ELDER PHARMA  FDC  SUN PHARMA  STRIDES PHARMA SCIENCE  TTK HEALTHCARE  

Compare DR. REDDYS LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 202 Points Lower; Britannia and Mahindra & Mahindra Among Top Nifty Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Related Views on News

NEULAND LABS Announces Quarterly Results (3QFY21); Net Profit Up 141.5% (Quarterly Result Update)

Feb 3, 2021 | Updated on Feb 3, 2021

For the quarter ended December 2020, NEULAND LABS has posted a net profit of Rs 267 m (up 141.5% YoY). Sales on the other hand came in at Rs 2 bn (up 20.5% YoY). Read on for a complete analysis of NEULAND LABS's quarterly results.

NEULAND LABS 2019-20 Annual Report Analysis (Annual Result Update)

Sep 2, 2020 | Updated on Sep 2, 2020

Here's an analysis of the annual report of NEULAND LABS for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of NEULAND LABS. Also includes updates on the valuation of NEULAND LABS.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

Top 3 Nifty ETFs to Buy Now(Fast Profits Daily)

Apr 20, 2021

In this video I tell you the three Nifty ETFs I think are the best.

A Stock with 700% Return Potential Comes with Additional Payoffs(Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

11x Bankruptcy to Bluechip Stock: A Rare India Revival Story(Profit Hunter)

Apr 16, 2021

There is no stopping this 11-bagger stock from significant upside.

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Apr 23, 2021 (Close)

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB - J.B.CHEMICALS COMPARISON

COMPARE DR. REDDYS LAB WITH

MARKET STATS